Mumbai: NCLT Approves ₹577.24-Crore Resolution Plan For Arch Pharmalabs Revival

The NCLT has approved a ₹577.24-crore resolution plan for Mumbai-based Arch Pharmalabs, paving the way for its revival. The consortium led by entrepreneur Ashish Kumar and Hyderabad-based MetaX Life Sciences proposes payments within 75 days, including ₹50 crore in fresh equity and provisions for creditors, employees and statutory dues.
Read the full report on The Free Press Journal
Story file
- Section
- Business
- Places
- Maharashtra, Telangana
- First reported by
- The Free Press Journal
- Reporter
- pranali lotlikar
- Published
- Friday, 23 October 2026, 2:28 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Free Press Journal with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

